FDA approves another over-the-counter naloxone nasal spray

The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone hydrochloride), for the emergency treatment of opioid overdose. The nonprescription approval was granted to Amphastar Pharmaceuticals.

source https://medicalxpress.com/news/2026-06-fda-counter-naloxone-nasal-spray.html